Clinical trial tech provider Clario has acquired neuroimaging startup NeuroRx, nearly a year after Clario filed for an IPO.
Why it matters: Amid unfavorable market conditions, Clario, backed by Nordic Capital and Astorg, is using alternative methods to strengthen its position in the clinical trials landscape.
